Effects of neonatal fluoxetine exposure on behavior across development in rats selectively bred for an infantile affective trait

Developmental Psychobiology

Volumn 57, Issue 2, 2015, Pages 141-152

  Zimmerberg, Betty ^a   Germeyan, Sierra C ^a  

^a WILLIAMS COLLEGE   (United States)

Author keywords

Antidepressant; Anxiety; Distress calls; Fluoxetine; Pregnancy; Rat; Social behavior; SSRI; Ultrasonic vocalization

Indexed keywords

ANIMALIA; RATTUS;

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

AFFECT; AGE; ANIMAL; ANIMAL BEHAVIOR; DRUG EFFECTS; FEMALE; GROWTH, DEVELOPMENT AND AGING; MALE; MOTOR PERFORMANCE; NEWBORN; PSYCHOLOGY; RAT; SEX DIFFERENCE; VOCALIZATION;

AFFECT; AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; FEMALE; FLUOXETINE; MALE; MOTOR SKILLS; RATS; SEROTONIN UPTAKE INHIBITORS; SEX FACTORS; VOCALIZATION, ANIMAL;

EID: 84923082094     PISSN: 00121630     EISSN: 10982302     Source Type: Journal    
DOI: 10.1002/dev.21264     Document Type: Article

References (45)

1. Allin, J. T., & Banks, E. M. ( 1972). Functional aspects of ultrasound production by infant albino rats (Rattus norvegicus). Animal Behavior, 20, 175-185.
2. Alwan, S., & Friedman, J. M. ( 2009). Safety of selective serotonin reuptake inhibitors in pregnancy. CNS Drugs, 23, 493-509.
3. Andersen, S. L. ( 2003). Trajectories of brain development: Point of vulnerability or window of opportunity. Neuroscience & Biobehavioral Reviews, 27, 3-18.
4. Ansorge, M. S., Morelli, E., & Gingrich, J. A. ( 2008). Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. Journal of Neuroscience, 28, 199-207.
5. Bamat, N. A., Brunelli, S. A., Kron, M. M., Schulte, A. R., & Zimmerberg, B. ( 2005). Behavioral effects of toluene in rats selectively bred for infantile vocalization rate. Neurotoxicology and Teratology, 27, 883-890.
6. Bayer, S. A., Altman, J., Russo, R. J., & Zhang, X. ( 1993). Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology, 14, 83-144.
7. Bock, N., Quentin, D. J., Hüther, G., Moll, G. H., Banaschewski, T., & Rothenberger, A. ( 2005). Very early treatment with fluoxetine and reboxetine causing long-lasting change of the serotonin but not the noradrenaline transporter in the frontal cortex of rats. World Journal of Biological Psychiatry, 6, 107-112.
8. Brunelli, S. A. ( 2005). Development and evolution of hidden regulators: Selective breeding for an infantile phenotype. Developmental Psychobiology, 47, 243-252.
9. Brunelli, S. A., & Hofer, M. A. ( 2007). Selective breeding for infant rat separation-induced ultrasonic vocalizations: Developmental precursors of passive and active coping styles. Behavioural Brain Research, 182, 193-207.
10. Brunelli, S. A., Nie, R., Whipple, C., Winiger, V., Hofer, M. A., & Zimmerberg, B. ( 2006). Selective breeding for infant ultrasonic vocalizations affects play behavior in juvenile rats. Physiology and Behavior, 87, 527-536.
11. Brunelli, S. A., Zimmerberg, B., & Hofer, M. A. ( 2010). Developmental effects of breeding for an infant trait. In K. E. Hood, C. T. Halpern & C. Greenberg (Eds.), Handbook of developmental science, behavior and genetics (pp. 285-322). Chichester: Wiley-Blackwell.
12. Carden, S. E., & Hofer, M. A. ( 1990). Independence of benzodiazepine and opiate action in the suppression of isolation distress in rat pups. Behavioral Neuroscience, 104, 160-166.
13. Cantor Sackett, J., Weller, R. A., & Weller, E. B. ( 2009). Selective Serotonin Reuptake Inhibitor use during pregnancy and possible neonatal complications. Current Psychiatry Reports, 11, 253-257.
14. Croen, L. A., Grether, J. K., Yoshida, C. K., Odouli, R., & Hendrick, V. ( 2011). Antidepressant use during pregnancy and childhood autism spectrum disorders. Archives of General Psychiatry, 68, 1104-1112.
15. Ferrara, A., El Bejaoui, S., Seyen, S., Tirelli, E., & Plumier, J. C. ( 2009). The usefulness of operant conditioning procedures to assess long-lasting deficits following transient focal ischemia in mice. Behavioral Brain Research, 205, 525-534.
16. Ferreira, E., Carceller, A. M., Agogue, C., Martin, B. Z., St-Andre, M., Francoeur, D., & Berard, A. ( 2007). Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates. Pediatrics, 119, 52-59.
17. Freund, N., Thompson, B. S., Denormandie, J., Vaccarro, K., & Andersen, S. L. ( 2013). Windows of vulnerability: Maternal separation, age, and fluoxetine on adolescent depressive-like behavior in rats. Neuroscience, 249, 88-97.
18. Fuente-Martín, E., García-Cáceres, C., Granado, M., Sánchez-Garrido, M. A., Tena-Sempere, M., Frago, L. M., Argente, J., & Chowen, J. A. ( 2012). Early postnatal overnutrition increases adipose tissue accrual in response to a sucrose-enriched diet. American Journal of Physiology: Endocrinology and Metabolism, 302, E1586-EE1598.
19. Gentile, S., & Galbally, M. ( 2011). Prenatal exposure to antidepressant medications and neurodevelopmental outcomes: A systematic review. Journal of Affective Disorders, 128, 1-9.
20. Germeyan, S. C., Iyer, M., Zarate, D., & Zimmerberg, B. ( 2012). Behavioral effects of postnatal fluoxetine administration in rats selectively bred for an infantile affective trait. Developmental Psychobiology, 54, 754.
21. Hadjikhani, N. ( 2010). Serotonin, pregnancy and increased autism prevalence: Is there a link? Medical Hypotheses, 74, 880-883.
22. Hendrick, V., Stowe, Z. N., Altshuler, L. L., Hwang, S., Lee, E., & Haynes, D. ( 2003). Placental passage of antidepressant medications. American Journal of Psychiatry, 160, 993-996.
23. Hodgson, R. A., Guthrie, D. H., & Varty, G. B. ( 2008). Duration of ultrasonic vocalizations in the isolated rat pup as a behavioral measure: Sensitivity to anxiolytic and antidepressant drugs. Pharmacology, Biochemistry and Behavior, 88, 341-348.
24. Ishiwata, H., Shiga, T., & Okado, N. ( 2005). Selective serotonin reuptake inhibitor treatment of early postnatal mice reverses their prenatal stress-induced brain dysfunction. Neuroscience, 133, 893-901.
25. Jeyakumar, M., Butters, T. D., Cortina-Borja, M., Hunnam, V., Proia, R. L., Perry, V. H., ... Platt, F. M. ( 1999). Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin. Proceedings of the National Academy of Sciences, 96, 6388-6393.
26. Karanges, E., Li, K. M., Motbey, C., Callaghan, P. D., Katsifis, A., & McGregor, I. S. ( 2011). Differential behavioural and neurochemical outcomes from chronic paroxetine treatment in adolescent and adult rats: A model of adverse antidepressant effects in human adolescents. The International Journal of Neuropsychopharmacology, 14(04), 491-504.
27. Karpova, N. N., Lindholm, J., Pruunsild, P., Timmusk, T., & Castrén, E. ( 2009). Long-lasting behavioural and molecular alterations induced by early postnatal fluoxetine exposure are restored by chronic fluoxetine treatment in adult mice. European Neuropsychopharmacology, 19, 97-108.
28. Knaepen, L., Rayen, I., Charlier, T. D., Fillet, M., Houbart, V., van Kleef, M., ... Pawluski, J. L. ( 2013). Developmental fluoxetine exposure normalizes the long-term effects of maternal stress on post-operative pain in Sprague-Dawley rat offspring. PLoS ONE, 8(2), 1-9.
29. Lee, L.-J., & Lee, L. J.-H. ( 2012). Neonatal fluoxetine exposure alters motor performances of adolescent rats. Developmental Neurobiology, 72, 1122-1132.
30. Moses-Kolko, E. L., Bogen, D., Perel, J., Bregar, A., Uhl, K., Levin, B., & Wisner, K. L. ( 2005). Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: Literature review and implications for clinical applications. Journal of the American Medical Association, 293, 2372-2383.
31. Oberlander, T. F., Gingrich, J. A., & Ansorge, M. S. ( 2009). Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: Molecular to clinical evidence. Clinical Pharmacology and Therapeutics, 86, 672-677.
32. Oberlander, T. F., & Wisner, K. L. ( 2012). A tale of 2s: Optimizing maternal-child health in the context of antenatal maternal depression and antidepressant use. Canadian Journal of Psychiatry, 57, 519-522.
33. Olivier, J. D., Akerud, H., Kaihola, H., Pawluski, J. L., Skalkidou, A., Högberg, U., & Sundström-Poromaa, I. ( 2013). The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring. Frontiers in Cellular Neuroscience., 7(Article 73), 1-15.
34. Olivier, J. D., Valles, A., van Heesch, F., Afrasiab-Middelman, A., Roelofs, J. J., Jonkers, M., & Homberg, J. R. ( 2011). Fluoxetine administration to pregnant rats increases anxiety-related behavior in the offspring. Psychopharmacology (Berl), 217, 419-432.
35. Rayen, I., van den Hove, D. L., Prickaerts, J., Steinbush, H. W., & Pawluski, J. L. ( 2011). Fluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescence. PLoS ONE, 6(9), 1-9.
36. Richards, E. M., & Payne, J. L. ( 2013). The management of mood disorders in pregnancy: Alternatives to antidepressants. CNS Spectrums, 1-11.
37. Rodriguez-Porcel, F., Green, D., Khatri, N., Harris, S. S., May, W. L., Lin, R. C. S., & Paul, I. A. ( 2011). Neonatal exposure of rats to antidepressants affects behavioral reactions to novelty and social interactions in a manner analogous to Autistic Spectrum Disorders. The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology, 294, 1726-1735.
38. Sarkar, A., Chachra, P., Kennedy, P., Pena, C. J., Desouza, L. A., Nestler, E. J., & Vaidya, V. A. ( 2014). Hippocampal HDAC4 contributes to postnatal fluoxetine-evoked depression-like behavior. Neuropsychopharmacology, 39, 2221-2232.
39. Simpson, K. L., Weaver, K. J., de Villers-Sidani, E., Lu, J. Y. F., Cai, Z., Pang, Y., ... Lin, R. C. S. ( 2011). Perinatal antidepressant exposure alters cortical network function in rodents. Proceedings of the National Academy of Sciences, 108, 18465-18470.
40. Tuccori, M., Montagnani, S., Testi, A., Ruggiero, E., Mantarro, S., Scollo, C., ... Blandizzi, C. ( 2010). Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: An update. Postgraduate Medicine, 122, 40-65.
41. Tuccori, M., Testi, A., Antonioli, L., Fornai, M., Montagnani, S., Ghisu, N., ... Del Tacca, M. ( 2009). Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: A review. Clinical Theraputics, 31, 1426-1453.
42. Whitaker-Azmitia, P. M. ( 2001). Serotonin and brain development: Role in human developmental diseases. Brain Research Bulletin, 56, 479-485.
43. Winslow, J. T., & Insel, T. R. ( 1991). The infant rat separation paradigm: A novel test for novel anxiolytics. Trends in Pharmacological Sciences, 12, 402-404.
44. Zimmerberg, B., Brunelli, S. A., Fluty, A. J., & Frye, C. A. ( 2005). Differences in affective behaviors and hippocampal allopregnanolone levels in adult rats of lines selectively bred for infantile vocalizations. Behavioral Brain Research, 159, 301-311.
45. Zimmerberg, B., Brunelli, S. A., & Hofer, M. A. ( 1994). Reduction of rat pup ultrasonic vocalizations by the neuroactive steroid allopregnanolone. Pharmacology, 47, 735-738.